Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07672483 IL-12 (SYTE) Refractory Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07672483 clinical trial report covering IL-12 (SYTE), Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07676357 RFUS-949 Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07676357 clinical trial report covering RFUS-949, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07675590 TIX-100 Overweight Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07675590 clinical trial report covering TIX-100, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07676266 C-CAR168 Neuromyelitis Optica Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07676266 clinical trial report covering C-CAR168, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07676903 SHR-4685 Solid tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07676903 clinical trial report covering SHR-4685, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07677358 Atirmociclib Hepatic Insufficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07677358 clinical trial report covering Atirmociclib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07675226 Cevidoplenib Purpura, Thrombocytopenic, Idiopathic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07675226 clinical trial report covering Cevidoplenib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07676877 Fludarabine Phosphate Diffuse large B-cell lymphoma refractory Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07676877 clinical trial report covering Fludarabine Phosphate, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262373 KH-607 Depressive Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262373 clinical trial report covering KH-607, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07677878 Blinatumomab Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07677878 clinical trial report covering Blinatumomab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262540 SYH2053 Renal Insufficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262540 clinical trial report covering SYH2053, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07677917 Dexmedetomidine Hydrochloride Agitation Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07677917 clinical trial report covering Dexmedetomidine Hydrochloride, Phase 1, endpoints, sponsor, geography, readout timing and development white spac
Read →
<
1
<<
1660
1661
1662
1663
1664
>>
2926
>